From: A case report of Nocardia spp. infective endocarditis in an injection drug user
References | Age (y)/sex | Predisposing risk factor | Site of involvement | Nocardia species | Antimicrobial treatment (Duration) | Surgery | Outcome | |
---|---|---|---|---|---|---|---|---|
Allevato et al. [8] | 53/M | PAV | RAA | N. asteroides | Streptomycin, tetracycline, vancomycin, sulfonamides | N/A | Died | |
Antony et al. [9] | 74/F | HTN, valvular heart disease, HLD | NMV | N. asteroides | Imipenem, ceftriaxone (6Â weeks), TMP-SMX (6Â months) | MVR | Survived | |
Antonovich et al. [10] | 83/F | COPD, MVP, breast & endometrial cancer, systemic steroids | NMV | N. asteroides | TMP-SMX | N/A | Survived | |
Cargill et al. [11] | 85/F | Ischemic heart disease, COPD, polymyalgia rheumatic, systemic steroids | NMV | N. cyriacigeorgica | Vancomycin, pip/tazo, imipenem, doxycycline | N/A | Died | |
Castelli et al. [12] | 36/M | Liver transplant | NMV | N. species | Ceftriaxone, vancomycin, TMP-SMX | MVR (× 2) | Survived | |
Daikos et al. [13] | 61/F | PAV | PAV | N. asteroides | Imipenem/cilastatin, amikacin (2Â months), TMP-SMX (4Â months) | N/A | Survived | |
Dhawan et al. [14] | 46/F | N/A | NMV | N. species | PCN, nafcillin, gentamicin, TMP-SMX, imipenem/cilastatin | MVR | Survived | |
Eigel et al. [15] | 61/M | PAV | PAV | N. asteroides | Amikacin, imipenem/cilastatin, cefotiam (3Â weeks) | AVR | Survived | |
Eigel et al. [15] | 65/M | PAV | PAV | N. asteroides | N/A | N/A | Died | |
Ertl et al. [16] | 61/M | PAV | PAV | N. asteroides | Amoxicillin, mezlocillin, tobramycin, sulphadiazine, amikacin, amoxicillin-clavulanate, imipenem (3Â weeks), TMP-SMX | AVR | Survived | |
Falk et al. [17] | 64/F | PAV | PAV | N. asteroides | Ampicillin, gentamicin | N/A | Died | |
Gupta et al. [18] | 53/F | History of breast cancer | NAV | N. species | Meropenem, amikacin, TMP-SMX, linezolid (8Â months) | AVR | Survived | |
Hazim et al. [19] | 64/M | Heart transplant, CKD | NTV | N. asteroides | TMP-SMX, imipenem/cilastatin, ceftriaxone, minocycline, linezolid (7Â months) | N/A | Survived | |
Jackson et al. [20] | 39/M | Splenectomy, tobacco use, HCV, IVDU | NTV | N. francinia | Meropenem, vancomycin, TMP-SMX | N/A | Lost to follow-up | |
Kuretski et al. [21] | 58/F | History of oral cancer, COPD, PFO repair, tobacco use | NMV | N. farcinica | Ceftriaxone, meropenem, amikacin, ciprofloxacin | MVR | Survived | |
Majeed et al. [22] | 72/M | Lymphoma | NMV | N. kroppenstedtii | Meropenem, TMP-SMX, levofloxacin, linezolid, ceftriaxone, minocycline, ciprofloxacin | N/A | Died | |
Vlachakis et al. [23] | 34/F | PMV, rheumatic heart disease | PMV | N. asteroides | N/A | N/A | Died | |
Watson et al. [24] | 39/M | IVDU | NAV | N. asteroides | Meropenem, ceftriaxone, amikacin, cefpodoxime, TMP-SMX (6Â months) | AVR | Survived |